WORLDQUANT MILLENNIUM ADVISORS LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1745981
NEW YORK, NY
Position in ALNY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,949,479
-$122,615,858 QoQ
Shares Held
42,160
-87.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WORLDQUANT MILLENNIUM ADVISORS LLC holds $237,388,644 across 14 Biotechnology names. ALNY ranks #4 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
100,669 | $77,780,896 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
622,304 | $60,519,064 | |
| 3 | INCY |
Incyte Corp
|
493,713 | $46,468,267 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
42,160 | $13,949,479 | |
| 5 | EXEL |
Exelixis, Inc.
|
236,324 | $10,135,936 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
202,420 | $5,607,034 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
214,587 | $4,669,413 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
23,677 | $4,476,136 |
All Filings in ALNY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,949,479 | 42,160 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $136,565,337 | 343,431 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $100,609,104 | 220,634 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $38,274,161 | 117,373 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $51,602,172 | 191,105 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $35,341,444 | 150,191 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $16,094,755 | 58,520 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $31,491,099 | 129,593 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,977,909 | 60,073 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $11,669,693 | 60,967 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $7,652,112 | 40,287 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,673,468 | 18,338 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $4,088,468 | 20,426 | Shares | Defined | 2022-11-14 | |
| 2021-06-30 | $5,424,470 | 31,999 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,056,106 | 28,728 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,733,778 | 28,728 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,182,796 | 28,728 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,321,186 | 42,679 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,934,492 | 36,146 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||